Press Room
Register
Subscribe

Contact Us

For more information on the VIVA Symposium or Late Breaking Clinical Trials, contact:

Susan O. Holtzman
305-975-5293
press@vivaphysicians.org

More »

Presentation Schedule

Late-Breaking Clinical Trials will be presented daily at VIVA 17 in the Global Theater beginning on Tuesday, September 11, 2017 and finishing on Wednesday, September 12. There will be two, one hour Late Breaking Clinical Trial Sessions each day.  To register to attend VIVA 17, please click Register button on the left sidebar.

Tuesday, Sept. 12

9:15 – 10:15 AM

 

Presenter

9:15 AM

A Unique Bioconvertible Inferior Vena Cava Filter: One-Year Results from the SENTRY Trial

Michael Dake, M.D.

9:24 AM

Questions from Panel

 

9:27 AM

Two-Year Results from the IN.PACT Global Study

Thomas Zeller, M.D.

9:36 AM

Questions from Panel

 

9:39 AM

Insights from the Zilver PTX Study in Japan

Michael Dake, M.D.

9:48 AM

Questions from Panel

 

9:51 AM

Primary Patency of a 3D Helical Stent: Significant Outcome from the Mimics Studyl

Thomas Zeller, M.D.

10:00 AM

Questions from Panel

 

10:03 AM

Four-Year Results of the IN.PACT SFA Trial: DCB Catheter vs. an Uncoated Balloon Catheter in Femoropopliteal Lesions

Peter Schneider, M.D.

10:12 AM

Questions from Panel

 

Tuesday, Sept. 12

1:15 – 2:15 PM

 

Presenter

1:15 PM

DANCE Trial: Two-year Outcomes from the 157-Limb Atherectomy Cohort

George Adams, M.D.

1:24 PM

Questions from Panel

 

1:27 PM

Twenty-Four-Month Results of Acotec DCB Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoro-popliteal Arteries (AcoArt I)

Wei Guo, M.D.

1:36 PM

Questions from Panel

 

1:39 PM

Safety and Efficacy of a Novel Percutaneous Bypass Procedure for Long-Segment Femoropopliteal: A Sub-Analysis from the DETOUR I Trial

Sean Lyden, M.D.

1:48 PM

Questions from Panel

 

1:51 PM

Clinical Outcomes Among Vascular Procedure Patients Receiving Suture-Mediated vs. Surgical Cutdown for Closure of Large Bore Arterial Access

Darren Schneider, M.D.

2:00 PM

Questions from Panel

 

2:03 PM

Interim 18-Month Results of the AV Trial: A Randomized Trial of DCB’s  in Hemodialysis Arteriovenous Fistulae

Gregory Nadolsky, M.D.

2:12 PM

Questions from Panel

 

Wednesday,   Sept. 13

9:15 – 10:15 AM

 

Presenter

9:15 AM

Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral, Ranger and Stellarex PCB’s in Healthy Swine

Aloke Finn, M.D.

9:24 AM

Questions from Panel

 

9:27 AM

CAS Benefit: Subgroup Analysis of ACT 1

Gary Ansel, M.D.

9:36 AM

Questions from Panel

 

9:39 AM

MarrOwStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe PAD: 24-Month Results from the MOBILE Trial

John Laird, M.D.

9:48 AM

Questions from Panel

 

9:51 AM

ILLUMENATE European Randomized Trial: Two-Year Results

Marianne Brodmann, M.D.

10:00 AM

Questions from Panel

 

10:03 AM

Five-year EVAR Outcomes Are Equivalent Between Genders: Results from the ENGAGE Registry

Mark Schermerhorn, M.D.

10:12 AM

Questions from Panel

 

Wednesday,   Sept. 13

1:15 – 2:15 PM

 

Presenter

1:15 PM

First Prospective Multicenter Study Evaluating Outcome Following EVAR in Women vs. Men: Early Results from the LUCY Study

Jennifer Ash, M.D.

1:24 PM

Questions from Panel

 

1:27 PM

Results of PREVEIL, DCB Feasibility Study

Gary Ansel, M.D.

1:36 PM

Questions from Panel

 

1:39 PM

The PRELUDE Study: Prospective Study for the Treatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator Device

Marianne Brodmann, M.D.

1:48 PM

Questions from Panel

 

1:51 PM

Use of a PCB to Treat Obstructive Lesions in the Superficial Femoral and Popliteal Arteries: Preliminary Results from the SAFE-DCB Trial

Edward Woo, M.D.

2:00 PM

Questions from Panel

 

2:03 PM

First-in-Human Experience with Endovascular Aneurysm Repair Using the Ovation Alto Stent Graft

Sean Lyden, M.D.

2:12 PM

Questions from Panel